Komori
Treasury shares4526RIKEN VITAMIN CO.,LTD.Food

Notice Regarding the Status of Share Repurchases and Completion of the Repurchase

Between 1 September and 18 September 2026, the company acquired 111,700 treasury shares for approximately ¥370 million, completing the acquisition of treasury shares based on the resolution dated 13 May.

Worth reading
70In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
370159496
¥
Wording
Definitive
How definitive the wording is.

Progress against acquisition limit

Acquisition completedMarket purchases on the Tokyo Stock Exchange

Resolved 13 May 2026 / Acquisition period 1 June 2026 to 30 September 2026

70.5%
Cumulative utilization rate
LimitAmount 99.9%265,700 株 remaining
Number of Shares900,000 shares (maximum)
99.9%
Cumulative utilization rate
Limit
Amount¥2,000,000,000 (maximum)

The darker band is the portion acquired this time (1 September 2026 to 18 September 2026). 金額の枠が先に埋まり、株数の上限は使い残しています。

Number of Shares
Limit900,000 shares (maximum)
Cumulative total634,300 shares (as of 18 September 2026)
Current111,700 shares
Amount
Limit¥2,000,000,000 (maximum)
Cumulative total¥1,999,927,975 (as of 18 September 2026)
Current¥370,159,496
Percentage of total issued shares3.08% (as a percentage of the total number of issued shares excluding treasury shares)
Average acquisition price for this transaction (calculated)¥3,314 per shareCurrent acquisition price ÷ current number of shares acquired
Whether acquisition has been completed

Acquisition completed. Completed with the shares acquired on 18 September 2026.

消化率と残りは、会社が示した累計・今回と上限から算出しています。進捗率=上限に対してどこまで使ったかの割合です。

Progress against acquisition limit
ItemDetails
Total number of shares acquired in this transaction111,700 shares
Total current acquisition price¥370,159,496
Acquisition date/acquisition period1 September 2026 to 18 September 2026
Method of acquisitionMarket purchases on the Tokyo Stock Exchange
Cumulative number of shares acquired634,300 shares (as of 18 September 2026)
Cumulative acquisition cost¥1,999,927,975 (as of 18 September 2026)
Resolution date13 May 2026
Maximum number of shares to be acquired900,000 shares (maximum)
Total acquisition price¥2,000,000,000 (maximum)
Acquisition period under the resolution1 June 2026 to 30 September 2026
Percentage of total issued shares3.08% (as a percentage of the total number of issued shares excluding treasury shares)
Whether acquisition has been completedAcquisition completed. Completed with the shares acquired on 18 September 2026.
Items this document does not state (1)
Average Acquisition Price

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The acquisition of treasury shares pursuant to the provision in the Articles of Incorporation under Article 165(2) of the Companies Act. The company stated that the acquisition based on the Board of Directors' resolution was completed with this acquisition, but gave no additional reason for its completion.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Status of Share Repurchases and Completion of the Repurchase | RIKEN VITAMIN CO.,LTD. (4526) timely disclosure | Komori